Articles On Anteo Diagnostics (ASX:ADO)

AnteoTech (ASX:ADO) has registered an updated EuGeni COVID-19 Rapid Antigen Test in Europe under the In Vitro Diagnostic Directive 98/79/EC Regulations.

ASX Small Cap index pops 1.4% rather nicely The top 200 ahead 1% AnteoTech and some clever diggers the big winners on Wednesday   The local small cap index is riding a mid-week mining boom with some standout individual performances from...

The All Ordinaries Index (ASX: XAO) is putting in another good show today, up 0.9% in early afternoon trading. While the 1.25% intraday lift by the benchmark is laudable, these two ASX All Ordinaries shares are rewarding shareholders with...

ShareCafeLunch Report: 18 May, 2022 by Melissa Darmawan   Materials lift ASX higher for 4th day Australian shares are on track to continue its winning streak for its fourth straight day after taking a strong lead from Wall St. The local ind...

The AnteoTech Ltd (ASX: ADO) share price is on the move today. This comes after the nanotechnology company announced a regulatory update regarding its COVID-19 Rapid Antigen Test (RAT). At the time of writing, AnteoTech shares are soaring...

Anteotech (ADO) successfully registers its updated EuGeni COVID-19 Rapid Antigen Test (RAT) in Europe under In Vitro Diagnostic Directive (IVDD) regulations The new registration strengthens the product’s competitive position as it broadens...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

Highlights The benchmark ASX 200 index was up 0.36% to 7,378.4 in the first 15 minutes of trading. Stocks on Wall Street ended on a strong note on Tuesday, led by a sharp gain in the tech-heavy NASDAQ Composite. The Information Techno...

The AnteoTech Ltd (ASX: ADO) share price is in the green today following some news from the company. AnteoTech shares are currently swapping hands at 10 cents, a 3.09% gain, after hitting 10.5 cents in early trading. In comparison, the S&...

Chief Executive Officer of AnteoTech (ADO) Derek Thomson is resigning Mr Thomson will serve his six month notice period alongside Executive Director, Christopher Parker The company’s board is beginning its search for a suitable replacemen...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. At the start of trade on Frida...

The Anteotech Ltd (ASX: ADO) share price is falling today after the healthcare company announced it has another hoop to jump through regarding its COVID-19 rapid antigen tests (RATs). At the time of writing, the AnteoTech share price is d...

AnteoTech (ADO) has once again been asked by the Therapeutic Goods Administration to provide more clinical data for the submission of its COVID-19 testing devices Since September, AnteoTech has been trying to get its EuGeni Reader platfor...

The AnteoTech Ltd (ASX: ADO) share price embraced February with arms wide open. So far, the new month has treated the biotechnology company much better than January. A month that saw AnteoTech shares plunge 36% as the Therapeutic Goods Ad...

ASX COVID-19 test shares are in the green today amid a federal government announcement. This morning Treasurer Josh Frydenberg outlined the government’s plan to make the tests tax deductible. ASX-listed companies that manufacture COVID-19...

Key points The AnteoTech share price shot 15% higher today It follows media speculation RATs not approved by the TGA may be imported into Australia Yesterday, the company’s shares fell 13% The AnteoTech Ltd (ASX: ADO) share price sur...

AnteoTech (ADO) reports cash outflows of $611,00 for the quarter, a drop from the previous quarter’s cash outflows of $2.35 million The reduction comes from receiving $1.96 million under the Federal Government’s Research and Development ta...

Key Points AnteoTech shares fall again on the back of a quarterly business update Management noted high barriers to market entry Company still in collaboration with TGA regarding regulatory approval for its RDT The AnteoTech Ltd (ASX: A...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small decline. At the time of writing, the benchmark index is down slightly to 6,987.1 points. Four ASX shares that are falling more than most today are list...

We examine the latest updates from Pointsbet Holdings [ASX:PBH], Weebit Nano [ASX:WBT], and AnteoTech [ASX:ADO]. The post Friday ASX News: Pointsbet, Weebit Nano, & Anteotech Shares in Focus appeared first on Money Morning Australia.

In late trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week with on a positive note. At the time of writing, the benchmark index is up 2.2% to 6,990.9 points. Four ASX shares that have failed to follow the market highe...

Key Points AnteoTech shares sink on additional request for information by the TGA The company submitted a performance report last week to the TGA Study timeline date impacted by Omicron outbreak and staff shortage across healthcare system...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

AnteoTech (ADO) receives a call for further information from the Therapeutic Goods Administration The new request relates to the collation of further clinical data on the company’s EuGeni Reader and SARS CoV- 2 Ag Rapid Diagnostic Test (RD...

Each week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength Index (RSI). The RSI is a technical gauge which measures how trading momentum is affecting the price action. A reading of 70 is seen as the le...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week deep in the red. At the time of writing, the benchmark index is down 2.1% to 7,182.8 points. Four ASX shares that have managed to avoid the selloff and p...

Key points The AnteoTech share price soared again today, taking its gains over the past week to 42% Demand for rapid antigen tests is increasing The company’s CEO is hitting media headlines this week The AnteoTech Ltd (ASX: ADO) shar...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a decline. At the time of writing, the benchmark index is down 1% to 7,399.7 points. Four ASX shares that are not letting that hold them back are li...

Key points Ellume is in the spotlight as the United States Government looks to buy another 500 million RATs Additionally, the company has reportedly started working to get approval to sell its tests in Australia There’s still no word of E...

Key points The Lumos Diagnostics share price is rising today COVID-19 rapid antigen tests are in focus this week The company’s CoviDX RAT test is waiting on TGA approval The Lumos Diagnostics Holdings Ltd (ASX: LDX) share price is risi...

Key points The AnteoTech share price is up 4% in early morning trade. The gain may relate to reports AnteoTech’s boss is hopeful its RAT device is in the final stages of TGA approval The company’s reportedly preparing to ramp up productio...

The S&P/ASX 200 Index (ASX: XJO) looks set to record its first decline of the year today. In afternoon trade, the benchmark index is down 0.3% to 7,565.7 points. Four ASX shares that are not letting that hold them back are listed below...

The AnteoTech Ltd (ASX: ADO) share price has soared since the start of the pandemic as the company has worked to create a COVID-19 rapid antigen test. Enthusiasm surrounding the now-developed point-of-care rapid testing device has helped...

In late morning trade, the S&P/ASX 200 Index (ASX: XJO) is fighting hard to record another gain. At the time of writing, the benchmark index is up slightly to 7,514.4 points. Four ASX shares that are climbing more than most today are l...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

Shares in Anteotech Ltd (ASX: ADO) are spiking well into the green during afternoon trade and now change hands 12.5% higher at 22.5 cents apiece. Whilst there’s been no market-sensitive information from the company’s end today, Anteotech...

Medical diagnosis technology company AnteoTech (ASX: ADO) has made the Brisbane Top Companies list for the first time as investor interest was buoyed by its relationship as a supplier to Ellume, another med-tech founded by former Brisbane Y...

It’s been a mad Monday on the ASX as the broader index struggled to mitigate a general sell-off, but the AnteoTech Ltd (ASX: ADO) share price has weathered the storm. At the market close, the company’s stock is trading flat with its previo...

The Anteotech Ltd (ASX: ADO) share price is falling in early trading this morning. This comes after the research and development company released its quarterly activities and earnings update. Shares in Anteotech are now changing hands at...

AM Diagnostics has been on the radar of many ASX-watchers recently. Particularly, after at-home COVID-19 antigen rapid tests, supplied by the Perth-based Australian company, received approval from the Therapeutic Goods Association (TGA) t...

Local markets looked brighter today. US share markets rebounded on Friday. Global oil prices also rose by around 1% on ahead of a meeting of OPEC+ producers today. Analysts expect that producers will add just 400,000 barrels per day in extr...

The Anteotech Ltd (ASX: ADO) share price has been soaring over the last 30 days on the back of numerous announcements. Over last month, the company has signed 3 distribution agreements and submitted its SARS-CoV-2 Antigen Rapid Diagnostic...

The AnteoTech Ltd (ASX: ADO) share price is rocketing today. This comes after news the company has submitted its SARS-CoV-2 antigen rapid diagnostic test for Therapeutic Goods Administration (TGA) approval. According to the company, its ra...

The ASX 200 has tracked lower in Friday trade, rounding out a choppy week where local stocks struggled for direction. The index was dragged lower by another brutal session for the big miners as iron ore prices tanked again, led by a 15% dro...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week deep in the red. At the time of writing, the benchmark index is down 0.8% to 7,400.6 points. Four ASX shares that are not letting that hold them back tod...

In afternoon trade, the S&P/ASX 200 index (ASX: XJO) is on course to finish in the green and is up 0.5% to 7,455.9 points. At the same time, the S&P/ASX 200 Health Care index (XHJ) is also up 0.7% from the open. Yet, these 3 ASX...

The AnteoTech Ltd (ASX: ADO) share price is accelerating to a 2-month high today. This comes after the surface chemistry company announced a distribution agreement for its EuGeni Rapid Diagnostic Platform. At the time of writing, AnteoTech...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has followed Wall Street’s lead and is storming higher. At the time of writing, the benchmark index is up 0.6% to 7,460 points. Four ASX shares that are climbing more than most today...

Anteotech (ASX:ADO) is another fine example of a chart pattern that we appreciate at Collette Capital. Namely a company that has demonstrated the capacity to put significant runs on the board when capturing the interest of the market, that...